Unknown

Dataset Information

0

Generation of human vascularized and chambered cardiac organoids for cardiac disease modelling and drug evaluation.


ABSTRACT: Human induced pluripotent stem cell (hiPSC)-derived cardiac organoids (COs) have shown great potential in modelling human heart development and cardiovascular diseases, a leading cause of global death. However, several limitations such as low reproducibility, limited vascularization and difficulty in formation of cardiac chamber were yet to be overcome. We established a new method for robust generation of COs, via combination of methodologies of hiPSC-derived vascular spheres and directly differentiated cardiomyocytes from hiPSCs, and investigated the potential application of human COs in cardiac injury modelling and drug evaluation. The human COs we built displayed a vascularized and chamber-like structure, and hence were named vaschamcardioids (vcCOs). These vcCOs exhibited approximately 90% spontaneous beating ratio. Single-cell transcriptomics identified a total of six cell types in the vcCOs, including cardiomyocytes, cardiac precursor cells, endothelial cells, fibroblasts, etc. We successfully recaptured the processes of cardiac injury and fibrosis in vivo on vcCOs, and showed that the FDA-approved medication captopril significantly attenuated cardiac injury-induced fibrosis and functional disorders. In addition, the human vcCOs exhibited an obvious drug toxicity reaction to doxorubicin in a dose-dependent manner. We developed a three-step method for robust generation of chamber-like and vascularized complex vcCOs, and our data suggested that vcCOs might become a useful model for understanding pathophysiological mechanisms of cardiovascular diseases, developing intervention strategies and screening drugs.

SUBMITTER: Yang J 

PROVIDER: S-EPMC11294415 | biostudies-literature | 2024 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Generation of human vascularized and chambered cardiac organoids for cardiac disease modelling and drug evaluation.

Yang Jingsi J   Lei Wei W   Xiao Yang Y   Tan Shuai S   Yang Jiani J   Lin Yingjiong Y   Yang Zhuangzhuang Z   Zhao Dandan D   Zhang Chunxiang C   Shen Zhenya Z   Hu Shijun S  

Cell proliferation 20240307 8


Human induced pluripotent stem cell (hiPSC)-derived cardiac organoids (COs) have shown great potential in modelling human heart development and cardiovascular diseases, a leading cause of global death. However, several limitations such as low reproducibility, limited vascularization and difficulty in formation of cardiac chamber were yet to be overcome. We established a new method for robust generation of COs, via combination of methodologies of hiPSC-derived vascular spheres and directly differ  ...[more]

Similar Datasets

| S-EPMC9773542 | biostudies-literature
2024-06-01 | GSE234907 | GEO
| S-EPMC10511847 | biostudies-literature
2022-10-10 | GSE168464 | GEO
2025-04-14 | GSE287136 | GEO
| PRJNA983720 | ENA
| S-EPMC7422941 | biostudies-literature
| S-EPMC10625054 | biostudies-literature
2025-11-06 | PXD019266 | Pride
2025-09-10 | GSE289261 | GEO